162 related articles for article (PubMed ID: 1268491)
1. Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure.
Prescott LF; Adjepon-Yamoah KK; Talbot RG
Br Med J; 1976 Apr; 1(6015):939-41. PubMed ID: 1268491
[TBL] [Abstract][Full Text] [Related]
2. Lignocaine and indocyanine green kinetics in patients following myocardial infarction.
Bax ND; Tucker GT; Woods HF
Br J Clin Pharmacol; 1980 Oct; 10(4):353-61. PubMed ID: 7448106
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting free (unbound) lignocaine concentration in suspected acute myocardial infarction.
Routledge PA; Stargel WW; Barchowsky A; Wagner GS; Shand DG
Br J Clin Pharmacol; 1989 Nov; 28(5):593-7. PubMed ID: 2590613
[TBL] [Abstract][Full Text] [Related]
4. Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease.
Forrest JA; Finlayson ND; Adjepon-Yamoah KK; Prescott LF
Br Med J; 1977 May; 1(6073):1384-7. PubMed ID: 861646
[TBL] [Abstract][Full Text] [Related]
5. Logical approach to lignocaine therapy.
Aps C; Bell JA; Jenkins BS; Poole-Wilson PA; Reynolds F
Br Med J; 1976 Jan; 1(6000):13-5. PubMed ID: 1247716
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of lignocaine.
Benowitz NL; Meister W
Clin Pharmacokinet; 1978; 3(3):177-201. PubMed ID: 350470
[TBL] [Abstract][Full Text] [Related]
7. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction.
Nattel S; Gagne G; Pineau M
Clin Pharmacokinet; 1987 Nov; 13(5):293-316. PubMed ID: 2891461
[TBL] [Abstract][Full Text] [Related]
8. Adenosine Plasma Level and A2A Receptor Expression in Patients With Cardiogenic Shock.
Gaubert M; Marlinge M; Kerbaul F; Resseguier N; Laine M; Cautella J; Cordier C; Colomb B; Kipson N; Thuny F; Mottola G; Fenouillet E; Ruf J; Paganelli F; Guieu R; Bonello L
Crit Care Med; 2018 Sep; 46(9):e874-e880. PubMed ID: 29923934
[TBL] [Abstract][Full Text] [Related]
9. Ventricular tachyarrhythmias and lignocaine prophylaxis in acute myocardial infarction. A clinical and therapeutic study.
Mogensen L
Acta Med Scand Suppl; 1970; 513():1-80. PubMed ID: 5288550
[No Abstract] [Full Text] [Related]
10. Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock.
Gjesdal G; Braun OÖ; Smith JG; Scherstén F; Tydén P
BMC Cardiovasc Disord; 2018 Jan; 18(1):8. PubMed ID: 29347907
[TBL] [Abstract][Full Text] [Related]
11. Lignocaine kinetics in cardiac patients and aged subjects.
Nation RL; Triggs EJ; Selig M
Br J Clin Pharmacol; 1977 Aug; 4(4):439-48. PubMed ID: 901735
[TBL] [Abstract][Full Text] [Related]
12. The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction.
Upward JW; Holt D; Emery P; Akhras F; Jackson G
Eur J Clin Pharmacol; 1983; 25(5):589-94. PubMed ID: 6420162
[TBL] [Abstract][Full Text] [Related]
13. Plasma lignocaine concentrations associated with extradural analgesia in patients with and without multiple organ failure.
Putensen C; Lingnau W; Putensen-Himmer G; Herold M
Br J Anaesth; 1992 Nov; 69(5):513-6. PubMed ID: 1467084
[TBL] [Abstract][Full Text] [Related]
14. Plasma adrenaline and noradrenaline concentrations and dopamine-beta-hydroxylase activity in myocardial infarction with and without cardiogenic shock.
Benedict CR; Grahame-Smith DG
Br Heart J; 1979 Aug; 42(2):214-20. PubMed ID: 486283
[TBL] [Abstract][Full Text] [Related]
15. Continuous infusion of lidocaine in patients with cardiac arrhythmias. Unpredictability of plasma concentrations.
Sawyer DR; Ludden TM; Crawford MH
Arch Intern Med; 1981 Jan; 141(1):43-5. PubMed ID: 7447583
[TBL] [Abstract][Full Text] [Related]
16. Plasma glycerol in acute myocardial infarction.
Wahal PK; Chauhan SP; Mehrotra MP; Gupta MC; Hazra DK; Jain VK; Maheshwari BB
Indian Heart J; 1980; 32(3):163-8. PubMed ID: 7409845
[No Abstract] [Full Text] [Related]
17. B-type natriuretic peptide and its molecular precursor in myocardial infarction complicated by cardiogenic shock.
Hejmdal A; Boesgaard S; Lindholm MG; Goetze JP
J Card Fail; 2007 Apr; 13(3):184-8. PubMed ID: 17448415
[TBL] [Abstract][Full Text] [Related]
18. [Use of intramuscular lidocaine in the acute stage of myocardial infarction].
Djiane P; Egre A; Perchicot B; Bory M; Serradimigni A; Bruguerolle B; Bouyard P
Arch Mal Coeur Vaiss; 1981 Aug; 74(8):931-8. PubMed ID: 6793010
[TBL] [Abstract][Full Text] [Related]
19. Lignocaine therapy after acute myocardial infarction.
Chopra MP; Portal RW; Aber CP
Br Med J; 1969 Jan; 1(5638):213-6. PubMed ID: 5762622
[TBL] [Abstract][Full Text] [Related]
20. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction.
Barchowsky A; Shand DG; Stargel WW; Wagner GS; Routledge PA
Br J Clin Pharmacol; 1982 Mar; 13(3):411-5. PubMed ID: 7059443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
